Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Brown

Showing results (1-10 of 375) with videos related to

Pageof 38
Sort By:
Haematologica|November 18, 2021
Response to Comment on: "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients"Jennifer R Brown
Leukemia & Lymphoma|May 15, 2015
The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy targetJennifer R Brown
Expert Review of Hematology|October 6, 2009
Inherited predisposition to chronic lymphocytic leukemiaJennifer R Brown
Blood|June 20, 2020
Inverting the BTK-BCL2 orderJennifer R Brown
Leukemia & Lymphoma|November 7, 2012
Gastric mucosa-associated lymphoid tissue lymphoma resistant to Helicobacter pylori eradication: what's the best option?Jennifer R Brown
Hematology. American Society of Hematology. Education Program|December 4, 2018
Relapsed CLL: sequencing, combinations, and novel agentsJennifer R Brown
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Phosphatidylinositol 3 Kinase δ Inhibitors: Present and FutureJennifer R Brown
Blood|December 19, 2015
Idelalisib has CLL on the run!Jennifer R Brown
Seminars in Oncology|April 5, 2016
The PI3K pathway: clinical inhibition in chronic lymphocytic leukemiaJennifer R Brown
Hematology/Oncology Clinics of North America|June 27, 2021
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges AheadJennifer R Brown
Pageof 38

Showing results (1-10 of 375) with videos related to

Sort By:
Pageof 38
Haematologica|November 18, 2021
Response to Comment on: "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients"Jennifer R Brown
Leukemia & Lymphoma|May 15, 2015
The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy targetJennifer R Brown
Expert Review of Hematology|October 6, 2009
Inherited predisposition to chronic lymphocytic leukemiaJennifer R Brown
Blood|June 20, 2020
Inverting the BTK-BCL2 orderJennifer R Brown
Leukemia & Lymphoma|November 7, 2012
Gastric mucosa-associated lymphoid tissue lymphoma resistant to Helicobacter pylori eradication: what's the best option?Jennifer R Brown
Hematology. American Society of Hematology. Education Program|December 4, 2018
Relapsed CLL: sequencing, combinations, and novel agentsJennifer R Brown
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Phosphatidylinositol 3 Kinase δ Inhibitors: Present and FutureJennifer R Brown
Blood|December 19, 2015
Idelalisib has CLL on the run!Jennifer R Brown
Seminars in Oncology|April 5, 2016
The PI3K pathway: clinical inhibition in chronic lymphocytic leukemiaJennifer R Brown
Hematology/Oncology Clinics of North America|June 27, 2021
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges AheadJennifer R Brown
Pageof 38